InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Johnson Marvin. Officer active across 1 company, notably Marinus Pharmaceuticals, INC.. In total, 5 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €834. Activity tracked since 17 April 2023. The latest transaction was disclosed on 7 February 2025 (Disposition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Johnson Marvin is a declarant linked to Marinus Pharmaceuticals, INC., where he is Director. He has 5 filings in total, and across the 5 recent filings reviewed, sales amount to EUR 3688, with no purchases, between 2023-04-19 and 2025-02-11; the most frequent transaction nature is Attribution.